1. Home
  2. GRFS vs STNE Comparison

GRFS vs STNE Comparison

Compare GRFS & STNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$9.02

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Logo StoneCo Ltd.

STNE

StoneCo Ltd.

HOLD

Current Price

$14.70

Market Cap

5.0B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
STNE
Founded
1940
2012
Country
Spain
Cayman Islands
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.0B
IPO Year
2006
2018

Fundamental Metrics

Financial Performance
Metric
GRFS
STNE
Price
$9.02
$14.70
Analyst Decision
Hold
Buy
Analyst Count
2
7
Target Price
$10.15
$17.21
AVG Volume (30 Days)
551.2K
6.8M
Earning Date
01-01-0001
11-06-2025
Dividend Yield
1.58%
N/A
EPS Growth
N/A
N/A
EPS
0.64
N/A
Revenue
$8,821,017,248.00
$2,670,485,228.00
Revenue This Year
$5.36
$17.50
Revenue Next Year
$5.15
$6.84
P/E Ratio
$17.99
N/A
Revenue Growth
7.31
24.14
52 Week Low
$6.19
$7.72
52 Week High
$11.14
$19.95

Technical Indicators

Market Signals
Indicator
GRFS
STNE
Relative Strength Index (RSI) 53.16 41.95
Support Level $8.69 $13.83
Resistance Level $9.22 $15.19
Average True Range (ATR) 0.18 0.56
MACD 0.03 0.02
Stochastic Oscillator 64.15 36.74

Price Performance

Historical Comparison
GRFS
STNE

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About STNE StoneCo Ltd.

StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services segment, which includes payments solutions, digital banking, credit, insurance solutions as well as the registry business. In the Software segment solution includes POS/ERP, TEF and QR Code gateways, reconciliation, CRM, OMS, e-commerce platform, engagement tool, ads solution, and marketplace hub. It generates the majority of its revenue from the Financial Services segment.

Share on Social Networks: